July 26, 2014 3:10 AM ET


Company Overview of Euclises Pharmaceuticals, Inc.

Company Overview

Euclises Pharmaceuticals, Inc. researches, develops, and commercializes medicines in the field of inflammation and oncology. Euclises Pharmaceuticals, Inc. was formerly known as Talley NewCo, Inc. The company was incorporated in 2011 and is based in St. Louis, Missouri.

4320 Forest Park Avenue

Suite 303

St. Louis, MO 63108

United States

Founded in 2011



Key Executives for Euclises Pharmaceuticals, Inc.

Co-Founder and Director
Age: 65
Co-Founder and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
NeoThera Biosciences, Inc. United States
Hisamitsu America Inc. United States
Vitruvias Therapeutics, LLC United States
YM BioSciences USA Inc. United States
ChanRx Corp. United States

Recent Private Companies Transactions

Private Placement
December 30, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Euclises Pharmaceuticals, Inc., please visit www.euclises.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.